247933-34-2Relevant academic research and scientific papers
THERAPEUTIC AGENTS I
-
Page/Page column 79-80, (2010/02/12)
Compounds of formula(I), processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders, and pharmaceutical compositions containing them.
Novel polyisocyanate compound, method for producing the same, and uses thereof
-
Page/Page column 5, (2010/02/11)
The invention provides an optical material being excellent in balance between the heat resistance, Abbe number and refractive index by providing a compound represented by the general formula (1): in the formula, k and n representing integers of 0 to 2 and 0 to 1, respectively, with the proviso that k and n are not simultaneously zero, and k=0 meaning that —(CH2)k- is not included in the formula.
